IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets

Suzanne M. Garland & Kimon Chatzistamatiou et al. · 2024-10-02

The global supply of human papillomavirus (HPV) prophylactic vaccines has been constrained since 2020.Vaccine manufacturers have increased capacity and new HPV vaccines are now available. Vaccine supply is now able to meet the full HPV vaccine demand which has been achieved earlier than predicted.
Journal
Vaccine
Authors
Suzanne M. Garland, Neerja Bhatla, Yin Ling Woo, Margaret Stanley, Andreas Kaufmann, Julia Brotherton, Anna-Barbara Moscicki, Anna Giuliano, Karen Chan, Sarah Feldman, Nicolas Wentzensen, Kimon Chatzistamatiou